GlassScriptPhysician profile
Ashley Brannon
NPI 1043632086
$9,120.74
in general payments reported to CMS, 2019-2025
32 companies · $1,071 in 2025
The $1,071 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,717 · 2022: $2,454 · 2023: $2,499 · 2024: $1,379 · 2025: $1,071.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,838 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,838.06 |
| Education | $111.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,241.26 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $1,198.65 | 2021-2025 | Rexulti |
| Alkermes, INC. | $810.30 | 2021-2025 | Aristada, Lybalvi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $583.13 | 2021-2025 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $522.33 | 2021-2025 | Austedo Xr, Austedo Xr, Austedo |
| Takeda Pharmaceuticals U.S.A., INC. | $448.55 | 2021-2024 | Trintellix |
| Corium, LLC | $446.82 | 2021-2025 | Azstarys |
| Lundbeck LLC | $425.74 | 2021-2025 | Rexulti |
| Ironshore Pharmaceuticals INC. | $396.28 | 2021-2024 | Jornay Pm |
| Neurocrine Biosciences, INC. | $357.93 | 2022-2024 | Ingrezza |
| Axsome Therapeutics, INC. | $284.84 | 2022-2025 | Auvelity |
| Tris Pharma INC | $282.23 | 2021-2025 | Dyanavel Xr |
| Supernus Pharmaceuticals, INC. | $264.99 | 2021-2025 | Qelbree, Qelbree |
| Neos Therapeutics, LP | $262.86 | 2021-2025 | Adzenys Xr-Odt |
| Bausch Health US, LLC | $251.81 | 2021-2025 | Aplenzin |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $211.85 | 2021-2025 | Spravato |
| Idorsia Pharmaceuticals US INC | $196.91 | 2022-2023 | Quviviq |
| Sunovion Pharmaceuticals INC. | $138.77 | 2022 | |
| Janssen Scientific Affairs, LLC | $109.80 | 2023 | Spravato |
| Eisai INC. | $90.52 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $89.22 | 2021-2025 | Fanapt |
| Vertical Pharmaceuticals, LLC | $78.68 | 2024-2025 | Relexxii |
| Arbor Pharmaceuticals, INC. | $63.74 | 2021-2022 | |
| Noven Therapeutics, LLC | $63.51 | 2023-2024 | Xelstrym, Secuado |
| Jazz Pharmaceuticals INC. | $63.46 | 2021 | |
| Merck Sharp & Dohme LLC | $47.98 | 2021-2022 | |
| Boston Scientific Corporation | $44.10 | 2023 | |
| Avanir Pharmaceuticals, INC. | $35.07 | 2021-2022 | |
| Alfasigma USA, INC. | $34.96 | 2021 | |
| Adlon Therapeutics L.P. | $28.96 | 2021 | |
| Owp Pharmaceuticals, INC. | $25.55 | 2022 | |
| Avion Pharmaceuticals | $19.94 | 2023 | Methylphenidate Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Brannon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.